|
ANAPC16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.56061879769732E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.360400E-01 |
| Stage1-vs-Stage3 |
8.176300E-02 |
| Stage1-vs-Stage4 |
9.902900E-03 |
| Stage2-vs-Stage3 |
3.208400E-01 |
| Stage2-vs-Stage4 |
7.350400E-02 |
| Stage3-vs-Stage4 |
3.117800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.33059999996021E-06 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
1.724190E-01 |
| Caucasian-vs-Asian |
2.147200E-01 |
| AfricanAmerican-vs-Asian |
5.253800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.457400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.50150003541683E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.338800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.505400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.022600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.487200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.800000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.143400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.057000E-03 |
| Classical-VS-Follicular |
4.66359999995447E-06 |
| Classical-VS-Other |
1.619380E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.05399999839051E-08 |
| Tall-VS-Other |
1.024010E-02 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
6.281800E-02 |
| Follicular-VS-Normal |
6.61409815805314E-11 |
| Other-VS-Normal |
1.86980000038695E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.096090E-02 |
|
|
